Extended Data Fig. 5: Mutant selective inhibition of RAS using morpholino.
From: Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers

Raw NGS reads showing KRAS Q61L transcript were visualized using IGV 2.8.0 software.
From: Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers
Raw NGS reads showing KRAS Q61L transcript were visualized using IGV 2.8.0 software.